Cargando…
Acute phase reaction during chemotherapy in small cell lung cancer.
We have measured the serum concentration of the acute phase reactant, C-reactive protein (CRP), in 20 patients with histologically proven small cell lung cancer undergoing their first pulse of induction cytotoxic chemotherapy. Baseline CRP concentrations were raised in 16 of 20 patients (median base...
Autores principales: | Milroy, R., Shapiro, D., Shenkin, A., Banham, S. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246740/ https://www.ncbi.nlm.nih.gov/pubmed/2544225 |
Ejemplares similares
-
A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group.
por: Milroy, R.
Publicado: (1993) -
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer
por: Baka, S, et al.
Publicado: (2008) -
Chemotherapy of non-small cell lung cancer.
por: Williams, C. J.
Publicado: (1989) -
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
por: Vardy, Janette, et al.
Publicado: (2009) -
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer.
por: Scott, H. R., et al.
Publicado: (1996)